StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2018, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 23 Mar 2018 16:30:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Aeolus Announces Commencement of Assignment for the Benefit of Creditors http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Commencement+of+Assignment+for+the+Benefit+of+Creditors/13980350.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Commencement+of+Assignment+for+the+Benefit+of+Creditors/13980350.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Commencement+of+Assignment+for+the+Benefit+of+Creditors/13980350.html Fri, 23 Mar 2018 16:30:00 -0500 AOLS Form 15-12G AEOLUS PHARMACEUTICALS, http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++AEOLUS+PHARMACEUTICALS%2C++++++++++++++/13629080.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++AEOLUS+PHARMACEUTICALS%2C++++++++++++++/13629080.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++AEOLUS+PHARMACEUTICALS%2C++++++++++++++/13629080.html Fri, 22 Dec 2017 16:53:00 -0500 AOLS Aeolus Announces Presentation of Pharmacometric Analysis Confirming Statistically Significant Improvement in Survival 6 Months After Exposure to Lethal Thoracic Radiation Following Treatment with AEOL http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Presentation+of+Pharmacometric+Analysis+Confirming+Statistically+Significant+Improvement+in+Survival+6+Months+After+Exposure+to+Lethal+Thoracic+Radiation+Following+Treatment+with+AEOL/13327611.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Presentation+of+Pharmacometric+Analysis+Confirming+Statistically+Significant+Improvement+in+Survival+6+Months+After+Exposure+to+Lethal+Thoracic+Radiation+Following+Treatment+with+AEOL/13327611.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Presentation+of+Pharmacometric+Analysis+Confirming+Statistically+Significant+Improvement+in+Survival+6+Months+After+Exposure+to+Lethal+Thoracic+Radiation+Following+Treatment+with+AEOL/13327611.html Tue, 26 Sep 2017 08:00:00 -0500 AOLS Aeolus Announces Presentation of Pharmacometric Analysis of Data Establishing Optimal Dose Schedule of AEOL 10150 for Treatment of Lung Radiation Damage http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Presentation+of+Pharmacometric+Analysis+of+Data+Establishing+Optimal+Dose+Schedule+of+AEOL+10150+for+Treatment+of+Lung+Radiation+Damage/13319678.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Presentation+of+Pharmacometric+Analysis+of+Data+Establishing+Optimal+Dose+Schedule+of+AEOL+10150+for+Treatment+of+Lung+Radiation+Damage/13319678.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Presentation+of+Pharmacometric+Analysis+of+Data+Establishing+Optimal+Dose+Schedule+of+AEOL+10150+for+Treatment+of+Lung+Radiation+Damage/13319678.html Fri, 22 Sep 2017 08:00:00 -0500 AOLS Aeolus Announces Publication of Data Demonstrating that Adding AEOL 10150 to Standard Therapy After Nerve Agent Exposure Improves Survival and Reduces Brain Damage and Nerve Inflammation in Rats http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Publication+of+Data+Demonstrating+that+Adding+AEOL+10150+to+Standard+Therapy+After+Nerve+Agent+Exposure+Improves+Survival+and+Reduces+Brain+Damage+and+Nerve+Inflammation+in+Rats+/13312397.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Publication+of+Data+Demonstrating+that+Adding+AEOL+10150+to+Standard+Therapy+After+Nerve+Agent+Exposure+Improves+Survival+and+Reduces+Brain+Damage+and+Nerve+Inflammation+in+Rats+/13312397.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Publication+of+Data+Demonstrating+that+Adding+AEOL+10150+to+Standard+Therapy+After+Nerve+Agent+Exposure+Improves+Survival+and+Reduces+Brain+Damage+and+Nerve+Inflammation+in+Rats+/13312397.html Wed, 20 Sep 2017 08:00:00 -0500 AOLS AEOLUS' AEOL 10150 is Safe and Well Tolerated in Phase 1 Study in Healthy Subjects http://www.streetinsider.com/Press+Releases/AEOLUS%27+AEOL+10150+is+Safe+and+Well+Tolerated+in+Phase+1+Study+in+Healthy+Subjects/13303551.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/AEOLUS%27+AEOL+10150+is+Safe+and+Well+Tolerated+in+Phase+1+Study+in+Healthy+Subjects/13303551.html for the full story. http://www.streetinsider.com/Press+Releases/AEOLUS%27+AEOL+10150+is+Safe+and+Well+Tolerated+in+Phase+1+Study+in+Healthy+Subjects/13303551.html Mon, 18 Sep 2017 08:00:00 -0500 AOLS Aeolus Announces Third Quarter Financial Results for Fiscal Year 2017 http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Third+Quarter+Financial+Results+for+Fiscal+Year+2017/13205582.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Third+Quarter+Financial+Results+for+Fiscal+Year+2017/13205582.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+Third+Quarter+Financial+Results+for+Fiscal+Year+2017/13205582.html Mon, 14 Aug 2017 18:10:00 -0500 AOLS Form 10-Q AEOLUS PHARMACEUTICALS, For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AEOLUS+PHARMACEUTICALS%2C+++For%3A+Jun+30/13205024.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AEOLUS+PHARMACEUTICALS%2C+++For%3A+Jun+30/13205024.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AEOLUS+PHARMACEUTICALS%2C+++For%3A+Jun+30/13205024.html Mon, 14 Aug 2017 17:08:00 -0500 AOLS Aeolus Announces FDA Fast Track Designation Granted to AEOL 10150 for Treatment of Patients With Lung Acute Radiation Syndrome Following a Radiologial or Nuclear Event http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html Thu, 08 Jun 2017 10:35:00 -0500 A.06822034 A.38925042 AOLS Aeolus Announces FDA Fast Track Designation Granted to AEOL 10150 for Treatment of Patients With Lung Acute Radiation Syndrome Following a Radiologial or Nuclear Event http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html Thu, 08 Jun 2017 10:35:00 -0500 A.06822034 A.38925042 AOLS Aeolus Announces FDA Fast Track Designation Granted to AEOL 10150 for Treatment of Patients With Lung Acute Radiation Syndrome Following a Radiologial or Nuclear Event http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html for the full story. http://www.streetinsider.com/Press+Releases/Aeolus+Announces+FDA+Fast+Track+Designation+Granted+to+AEOL+10150+for+Treatment+of+Patients+With+Lung+Acute+Radiation+Syndrome+Following+a+Radiologial+or+Nuclear+Event/12993479.html Thu, 08 Jun 2017 10:35:00 -0500 A.06822034 A.38925042 AOLS Form 10-Q AEOLUS PHARMACEUTICALS, For: Mar 31 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AEOLUS+PHARMACEUTICALS%2C+++For%3A+Mar+31/12908050.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AEOLUS+PHARMACEUTICALS%2C+++For%3A+Mar+31/12908050.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AEOLUS+PHARMACEUTICALS%2C+++For%3A+Mar+31/12908050.html Mon, 15 May 2017 17:59:00 -0500 AOLS